Quoin Pharmaceuticals
Rare Diseases are only rare if you don't live with one.
5 employees · est. 2018 · Ashburn, United States
Quoin Pharmaceuticals is the older company (2019 vs 2018); Cyrus Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Cyrus Therapeutics | Quoin Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2018 older |
| Headquarters | ||
| Headquarters | Seoul, Korea South | Ashburn, United States |
| Employees | ||
| Employees | 15 larger | 5 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series B | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $39.00B | $13.69M |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Medicines, Innovation, Chronic Diseases, Life-threatening Diseases, Small Molecule Drugs, Chemical Modalities, Protein Degraders, Drug Discovery, Therapeutics, Biopharmaceuticals | Rare Diseases, Orphan Diseases, Specialty Pharmaceutical Company, Therapeutic Products, Unmet Medical Needs, Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, Pipeline Development, Sales Infrastructure, Licensing Partnerships, Underserved Patient Populations, Chronic Rare Skin Diseases, Strategic Partnerships |
| Website | ||
| Website | cyrustx.com | quoinpharma.com |
About Cyrus Therapeutics
Cyrus Therapeutics is a promising biotechnology company that was founded in 2019 in South Korea. The company's mission, 'drugging the undruggable targets,' emphasizes its dedication to developing innovative medicines for chronic or life-threatening diseases with high unmet needs. Utilizing small mol...
About Quoin Pharmaceuticals
Quoin Pharmaceuticals, founded in 2018, is an emerging specialty pharmaceutical company with a focus on developing and commercializing therapeutic products for rare and orphan diseases. The company's innovative pipeline comprises three products that have the potential to target a broad number of rar...
We will tell you when either one moves
BounceWatch watches Cyrus Therapeutics and Quoin Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cyrus Therapeutics and Quoin Pharmaceuticals — by email.
Frequently Asked Questions
Compare Cyrus Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cyrus Therapeutics on 11 Sep 2024, and Quoin Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
